Fund Holdings — B Group, Inc.

Total Portfolio Value:
$162.13M
Total Bought:
$6.67M
Total Sold:
$3.27M
Net Transaction:
+$3.41M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc3,262,5423,262,5420$27.31M$32.72M20.18%+$5.42M
Faeth Therapeutics Inc610,169610,1690$15.25M$18.15M11.19%+$2.89M
Palisade Bio Inc11,414,28511,414,2850$23.86M$15.41M9.50%-$8.45M
Nrx Pharmaceuticals Inc4,091,7674,277,200+185,433$16.74M$12.49M7.70%-$4.25M
Zai Lab LimitedADR(ZLAB)450,646450,6460$8.56M$11.87M7.32%+$3.31M
Praxis Precision Medicines, Inc.(PRAX)33,23733,2370$11.13M$9.68M5.97%-$1.45M
Sight Sciences Inc970,000970,0000$3.66M$9.08M5.60%+$5.42M
Taysha Gene Therapies, Inc.(TSHA)1,800,5561,800,5560$12.26M$8.77M5.41%-$3.49M
Iovance Biotherapeutics, Inc.(IOVA)1,500,000425,000-1,075,000$6.24M$6.30M3.88%+$58.5K
Structure Therapeutics IncADS140,000180,000+40,000$7.51M$5.63M3.47%-$1.89M
Spyre Therapeutics, Inc.(SYRE)70,00062,500-7,500$6.21M$5.56M3.43%-$650.2K
Cellectis S AADS3,281,5013,281,5010$9.84M$4.96M3.06%-$4.89M
Aura Biosciences Inc764,243764,2430$5.43M$4.80M2.96%-$626.7K
Bright Minds Biosciences Inc67,50095,000+27,500$4.74M$4.73M2.92%-$5.6K
Oruka Therapeutics, Inc.(ORKA)75,00055,000-20,000$7.14M$4.58M2.83%-$2.56M
Assembly Biosciences Inc175,706175,7060$4.83M$4.13M2.55%-$701.1K
Ultragenyx Pharmaceutical Inc.(RARE)135,000135,0000$4.51M$2.03M1.25%-$2.48M
Foghorn Therapeutics Inc200,000200,0000$976.0K$714.0K0.44%-$262.0K
Q32 Bio Inc065,000+65,000$0$537.5K0.33%+$537.5K
Page 1 of 1
B Group, Inc. — 13F Holdings — Q3 2026 | TickerTrail